Skip to main content

Table 1 Demographic data for study subjects

From: Dose selection method for pharmacokinetic study in hemodialysis patients using a subpharmacological dose: oseltamivir as a model drug

 

Low dose determination pilot study (n = 4)

Low dose study and method validation (n = 10)

Age (yr)

56.8 (14.8)

52.4 (14.2)

Sex (male: female)

2:2

6:4

Dry weight (Kg)

50.3 (13.4)

52.9 (12.1)

Body mass index (kg/m2)

20.6 (5.0)

20.1 (3.0)

Cause of ESRD (n)

  

  Chronic glomerulonephritis

2

4

  Hypertension

1

3

  Unknown

1

3

Time on hemodialysis

3.3 (0.8)

4.1 (1.6)

Hemoglobin (g/dL)

10.50 (0.58)

10.88 (0.92)

Dialysis efficiency

  

(at 44–48 hr of study period)

  

  Single-pool Kt/VUrea

1.47 (0.10)

1.58 (0.28)

  Urea reduction ration (%)

70.7 (2.1)

73.5 (5.3)

  Ultrafiltration rate (L/session)

2.60 (0.13)

2.10 (0.76)

  1. Data presented mean (standard deviation) or numbers.